Neurological Complications of Cocaine and Ketamine

COCAINE

Mechanism of CNS Toxicity

1. Cerebrovascular Complications (most common neurological manifestation)

• Subarachnoid hemorrhage (SAH) and intracerebral hemorrhage (ICH) are both seen
• ~50% of patients have an underlying vascular lesion (AVM or aneurysm) that ruptures due to cocaine-induced surges in blood pressure and heart rate
• When no vascular malformation is found, hemorrhage is most commonly in the basal ganglia and thalamus
• Risk of hemorrhage increases substantially with concurrent alcohol abuse
• A 2024 systematic review and meta-analysis (PMID: 38072159) specifically examined aneurysmal SAH with cocaine consumption

• Vasospasm / vasoconstriction - focal constrictions visible on angiography ("pearl and string" sign)
• Vasculitis - caused by cocaine itself or its adulterants (contrast enhancement of vessel walls on MRI)
• Thrombosis - cocaine increases platelet response to arachidonic acid, raises thromboxane levels, enhancing platelet aggregation leading to thrombotic infarcts
• Emboli - from cardiac arrhythmias (cocaine-induced dysrhythmias can produce cardioembolic events)

• Subcortical white matter
• Middle cerebral artery territory
• Mesencephalic infarcts are more frequent when cocaine is combined with amphetamines
• Bilateral cerebellar infarction has also been reported

Fig. - Cocaine-induced vascular diseases: capsulo-lenticular hemorrhage with "pearl and string" angiographic vasculitis (A-B); ischemic stroke in MCA territory with active vessel wall inflammation (C-D); acute bilateral cerebellar infarction (E-F). (Source: Grainger & Allison's Diagnostic Radiology)

2. Seizures

• Single generalized tonic-clonic seizures (most common)
• Status epilepticus in overdose
• Can occur with any route of use (intranasal, smoked, intravenous)
• Particularly dangerous because they may herald a stroke or can be the presenting feature of ICH

3. Levamisole-associated Multifocal Inflammatory Leukoencephalopathy

4. Chronic Brain Atrophy

• Chronic cocaine users develop cerebral atrophy, particularly affecting the frontal lobe (most severely) followed by the temporal lobe
• The mechanism is believed to be chronic ischemia from repeated endothelial damage causing premature atherosclerosis
• Subcortical white matter changes from microvascular pathology accumulate over time

5. Movement Disorders

• "Crack dancing" - stereotyped repetitive movements
• Choreiform movements have been reported, related to dopaminergic excess in the basal ganglia
• These are typically reversible with cessation of use

6. Headache

7. CNS Infections

KETAMINE

Mechanism of CNS Effects

1. Acute Dissociative Syndrome ("K-hole")

• Dose-dependent effects ranging from mild disorientation and illusions to full dissociation
• At recreational doses: euphoria, altered sensory perception, depersonalization, "out of body" experience
• Higher doses: catatonia, complete dissociation, unresponsiveness with preserved airway reflexes
• Duration: ~1 hour after insufflation (snorting), up to 4-8 hours after oral ingestion
• Route of street use: predominantly insufflation, but also IM injection and oral routes - Rosen's Emergency Medicine

2. Psychosis and Psychiatric Complications

• Ketamine blocks NMDA receptors and reproduces both positive symptoms (hallucinations, delusions) and negative symptoms (blunted affect, social withdrawal) of schizophrenia - making it the pharmacological model of schizophrenia in research
• Chronic users, even at low doses, can experience persistent psychiatric symptoms similar to schizophrenia
• The NMDA hypofunction hypothesis: impaired NMDA receptors on GABAergic interneurons in prefrontal cortex lead to downstream hyperdopaminergia, explaining the psychosis
• Emergence reactions/delirium on recovery from anesthetic doses

3. Cognitive Impairment

• Chronic recreational use is associated with memory impairment (especially episodic and working memory)
• Persistent cognitive deficits have been documented in long-term ketamine abusers
• NMDA receptors are critical for long-term potentiation (LTP) - the cellular substrate of memory - explaining why their chronic blockade impairs cognition

4. Seizures

• Ketamine can increase seizure activity in a dose-dependent manner
• However, at sub-anesthetic doses it may actually raise the seizure threshold
• Seizures are more commonly a feature of high-dose toxicity, especially when street preparations are adulterated with stimulants

5. Increased Intracranial Pressure

• Ketamine increases cerebral blood flow (unique among anesthetics) - a concern in patients with TBI or raised ICP
• This effect is mediated via cerebral vasodilation
• This side effect can be minimized by concurrent benzodiazepine use

6. Neurological Signs with Overdose/High-Dose Intoxication

• Ataxia
• Nystagmus (horizontal, vertical; vertical and horizontal nystagmus are hallmarks of dissociative intoxication)
• Muscle rigidity and increased deep tendon reflexes
• Bizarre posturing, grimacing
• Hyperthermia (mild to severe)
• Rhabdomyolysis (from muscle hyperactivity or seizures) - can lead to myoglobinuric renal failure
• Rarely: intracerebral hemorrhage from severe hypertension (more commonly seen with PCP)

7. Neurotoxicity (chronic/high-dose)

• A 2025 review (PMID: 40015548) specifically addresses the molecular mechanisms of programmed cell death in ketamine-induced neuronal damage
• Mechanisms include: mitochondrial dysfunction, oxidative stress, apoptosis pathways
• Particularly concerning in the developing brain (neonatal/pediatric exposure) - Harriet Lane Handbook
• The metabolite hydroxynorketamine (HNK) has emerged as the mediator of antidepressant effects via AMPA receptor activation, but the neurotoxic pathways involve direct NMDA blockade-mediated apoptosis in neurons - Goldman-Cecil Medicine

8. Urological Complications (indirect neurological relevance)

• Chronic ketamine use causes a distinct uropathy (ketamine cystitis) - urinary frequency, nocturia, and in severe cases, upper urinary tract destruction
• This is not directly a neurological complication, but the associated chronic pain can have central sensitization consequences

Summary Comparison Table

Chronic Neurological Disorders Persisting After Stopping Cocaine and Ketamine (1 Month into Abstinence)

COCAINE - Chronic/Persistent Neurological Disorders

1. Post-Stroke Neurological Deficits (most significant)

• Hemiparesis / hemiplegia - from MCA territory ischemic stroke (most common distribution)
• Aphasia - dominant hemisphere involvement
• Cerebellar ataxia - from posterior circulation infarcts (bilateral cerebellar infarction reported with cocaine)
• Hemianopia - from occipital or PCA territory involvement
• Basal ganglia / thalamic syndromes - from the typical sites of cocaine-related ICH (involuntary movements, sensory disturbances, thalamic pain)

A 2024 meta-analysis (PMID: 38072159) confirmed cocaine's strong association with aneurysmal SAH - patients surviving SAH carry permanent neurological and neuropsychological sequelae.

2. Chronic Cerebral Atrophy and Neurodegenerative Changes

• Frontal lobe atrophy is the most characteristic finding in chronic cocaine users - the frontal lobe is most severely affected, followed by the temporal lobe
• Mechanism: repeated endothelial damage → premature atherosclerosis → chronic ischemia → neuronal loss - Grainger & Allison's Diagnostic Radiology
• At 1 month abstinence, structural atrophy does NOT reverse - this is a fixed lesion
• Neurometabolic signature on MR spectroscopy: lower N-acetylaspartate (NAA, a marker of neuronal integrity), lower creatine, and higher myo-inositol (glial activation marker) in the medial prefrontal cortex - a profile that parallels Alzheimer's disease and mild cognitive impairment - 2023 meta-analysis, PMID: 37148676

3. Chronic Cognitive Impairment

• Frontally mediated functions are most impaired, consistent with the frontal atrophy pattern
• Dopaminergic dysfunction in prefrontal-striatal circuits persists well beyond acute withdrawal

4. Persistent Dopamine System Dysregulation - Anhedonia and Depression

• Chronic cocaine use depletes dopamine at nerve terminals through receptor downregulation and DAT upregulation
• At 1 month, dopaminergic recovery is incomplete - patients typically experience anhedonia (inability to feel pleasure), dysphoria, and depression that can persist for weeks to months
• This is not simply "feeling sad" - it represents a neurobiological state of dopamine D2 receptor hypofunction in the reward circuitry - Tintinalli's Emergency Medicine
• This "protracted withdrawal" phase carries significant relapse risk

5. White Matter Changes (Subcortical Leukoencephalopathy)

• Chronic microvascular ischemia produces diffuse subcortical and periventricular white matter hyperintensities on T2/FLAIR MRI
• These reflect small vessel disease accelerated by repeated vasospasm and endothelial injury
• Not reversible at 1 month abstinence
• Contribute to the cognitive slowing and executive dysfunction described above

6. Levamisole-Induced Leukoencephalopathy (if cocaine was adulterated)

• A subset of patients exposed to levamisole-adulterated cocaine develop multifocal inflammatory white matter lesions
• These can persist and even progress even after stopping cocaine - an immune-mediated process that may require immunosuppressive treatment
• MRI shows pseudo-tumoral inflammatory WM lesions

7. Seizure Disorder (Epilepsy)

• A single seizure during cocaine use is usually provoked and does not mandate long-term anticonvulsant treatment
• However, if the patient has underlying structural brain damage (prior stroke, WM changes), they are at increased risk for unprovoked recurrent seizures (i.e., epilepsy)
• At 1 month, provoked seizures from cocaine are no longer occurring, but if seizures continue, structural epilepsy must be considered

8. Movement Disorders (residual)

• Choreiform movements related to dopaminergic hypersensitivity usually resolve with abstinence but may take several weeks
• In patients with basal ganglia hemorrhage, permanent movement abnormalities (dystonia, choreic movements) may persist

KETAMINE - Chronic/Persistent Neurological Disorders

1. Persistent Psychosis / Schizophrenia-Like Disorder

• Chronic low-dose ketamine users can experience persistent psychiatric symptoms similar to schizophrenia - including both positive (delusions, hallucinations) and negative symptoms (blunted affect, avolition, social withdrawal) - Rosen's Emergency Medicine
• Mechanism: chronic NMDA receptor blockade on GABAergic interneurons → disinhibition of dopamine release → persistent dopaminergic dysregulation even after cessation
• At 1 month, these symptoms may still be active or worsening as neuroadaptation occurs
• Distinguishing drug-induced persistent psychotic disorder from primary schizophrenia is a key clinical challenge at this stage

2. Cognitive Impairment

• A 2025 review in the American Journal of Psychiatry (PMID: 40926573) confirmed that frequent high-dose users (>1 g/day) show memory and executive function impairments that persist after cessation
• These deficits are worse in those who used daily at high recreational doses compared to infrequent users

3. Olney Lesions and Structural Neurotoxicity

• NMDA receptor antagonists produce Olney lesions - vacuolization and neuronal injury in specific brain regions, particularly the posterior cingulate and retrosplenial cortices, in animal models
• [PMID: 35502632] (2022 review): daily high-dose ketamine use in substance use disorder populations was associated with clear neurotoxic effects; Olney lesions and tau hyperphosphorylation are concerns with chronic high-dose exposure
• At 1 month post-cessation, if neuronal damage occurred, it is unlikely to reverse significantly

4. Persistent Dissociative Episodes / Flashbacks

• Some chronic users experience spontaneous dissociative episodes without the drug - similar to "flashbacks" described with hallucinogens
• Perceptual distortions, depersonalization, and derealization can recur in the weeks following cessation
• These typically diminish over weeks to months but can persist in heavy users

5. Cerebellar and Balance Dysfunction

• Chronic exposure to NMDA antagonists impairs cerebellar-dependent motor learning
• Ataxia, gait instability, and balance problems may persist beyond acute intoxication

Combined Use: Special Considerations

1. Cardiovascular synergy - cocaine's vasoconstrictive/hypertensive effects plus ketamine's catecholamine release (tachycardia, HTN) creates extreme hemodynamic stress, increasing stroke risk
2. Dopamine + NMDA system dual disruption - cocaine depletes dopamine while ketamine disrupts NMDA-mediated glutamate signaling; this produces a complex, compounded neurochemical deficit state that is harder to recover from than either alone
3. Additive cognitive impairment - frontal executive dysfunction from both agents converges
4. Psychosis risk - cocaine-induced paranoid psychosis on the background of ketamine-induced NMDA hypofunction is a powerful recipe for persistent psychotic symptoms
5. Depression severity - dopamine depletion (cocaine) compounded by glutamatergic dysregulation (ketamine) produces refractory post-withdrawal depression

Timeline of Recovery at 1 Month

Clinical Bottom Line

1. Cognitive impairment - neuropsychological testing recommended
2. Persistent psychosis or mood disorder - psychiatric evaluation
3. Structural brain lesions - MRI brain with FLAIR to evaluate for WM changes, prior infarcts, atrophy
4. Epilepsy - EEG if there is any history of seizures
5. Depression/anhedonia - closely monitored; antidepressant therapy may be warranted